Cargando…
Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?
AIM: To investigate whether increased YKL-40 levels positively correlate with graft-vs-host disease (cGVHD) activity and severity and if YKL-40 could serve as a disease biomarker. METHODS: This case-control study was conducted at the University Hospital Centre Zagreb from July 2013 to October 2015....
Autores principales: | Duraković, Nadira, Krečak, Ivan, Perić, Zinaida, Milošević, Milan, Desnica, Lana, Pulanić, Dražen, Pusic, Iskra, Kušec, Vesna, Vrhovac, Radovan, Pavletic, Steven Z., Nemet, Damir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Medical Schools
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937225/ https://www.ncbi.nlm.nih.gov/pubmed/27374825 http://dx.doi.org/10.3325/cmj.2016.57.239 |
Ejemplares similares
-
Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters
por: Vukić, Tamara, et al.
Publicado: (2016) -
High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease
por: Čeović, Romana, et al.
Publicado: (2016) -
Vitamin D levels and their associations with survival and major disease outcomes in a large cohort of patients with chronic graft-vs-host disease
por: Katić, Mašenjka, et al.
Publicado: (2016) -
Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?
por: Perić, Zinaida, et al.
Publicado: (2016) -
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease
por: Sánchez-Ortega, Isabel, et al.
Publicado: (2016)